LEXARIA - 13G

Company

Lexaria Bioscience Corp.

Filed

February 14, 2022

Accession Number

0001769456-22-000003

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →